Ogilvy Public Relations
TMP Worldwide Advertising
Value-added expertise and innovation unmatched in our industry, and a client list that speaks for itself.
Shugoll Research is proud to serve some of the world's leading organizations with marketing and opinion research. We consider our client list to be a testament to the superior work we deliver, and the vast experience we've gathered across a variety of industries.
“Over the years, Shugoll Research has proven to be an incredibly valuable partner of the National Pork Board (NPB). Together we have journeyed down a path towards a better understanding of consumer’s purchasing decisions for fresh meat. Shugoll Research has been instrumental in assisting the NPB in development of countless strategies, none more important than our current brand position: Pork. Be Inspired.® The team at Shugoll Research played a key role in assessing consumer attitudes towards pork products.”
- Jarrod S., Director of Retail Marketing
“Shugoll’s ability to quickly adapt to the changing needs of our project was critical to ensuring timely and successful completion of work. Their skilled design team helped us to develop the brand name and logo for a new international awards competition that will recognize the most energy efficient products in the world. The extensive market research conducted by Shugoll resulted in a positive reception of the new brand name and logo by a variety of stakeholders from around the globe.”
- Christine E., Executive Director
“The Cystic Fibrosis Foundation (CFF) has been collaborating with Shugoll Research for the past six years on its annual survey of financial issues and concerns among cystic fibrosis patients and families. The survey provides the CFF with key information about health insurance and financial barriers that cystic fibrosis patients face in obtaining access to life-saving medications. The CFF shares this information with public policy makers and key stakeholders in the CF community. The survey results have been instrumental in helping the CFF ensure access to prescription medications and treatment for cystic fibrosis patients.”
- Dan K., Senior Vice President